BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE: MIL) and Stem Cell Sciences (SCS) today announced an exclusive license for Millipore to develop and market SCS’ serum free media for the growth of human embryonic stem cells (hESCs). The defined media will be the first product available in the industry that offers improved methods for growing hESCs without the need for animal serum.
